MariMed Presenting at 10th Annual LD Micro Main Event's First Ever Cannabis-Focused Session

MariMed Added to Marijuana Index of Top Performing Public Cannabis Companies

LOS ANGELES, CA and NEWTON, MA / November 27, 2017 / MariMed Inc. (OTCQB: MRMD) will be presenting at the 10th annual LD Micro Main Event on Wednesday, December 6, at 1:00 PM PST / 4:00 PM EST as part of the event's first ever session focusing solely on Cannabis-related companies. Mr. Robert Fireman, CEO of MariMed Inc. will be highlighting MariMed's achievements of developing and operating some of the nation's most acclaimed cannabis cultivation, production, and dispensing facilities in multiple state-licensed cannabis programs. He also will share details of the expansion of MariMed's Kalm Fusion™ and Betty's Eddies™ brands of precision-dosed, cannabis-infused products that are being licensed in multiple states to hundreds of dispensaries. To arrange a meeting with management, please contact Tyler Troup at tyler@circadian-group.com or 1-647-930-1037.

"We are honored to have MariMed present at our 10th annual Main Event," said Chris Lahiji, President of LD MICRO. "As more and more states legalize cannabis, the opportunities for companies in this space will be vast in the coming years. Hopefully, I will be lucky enough to enjoy MariMed's Betty's Eddies Fruit Chews at the conference. Hosting an event of this size can give even grizzled veterans a headache."

The conference will be held at the Luxe Sunset Bel Air Hotel, in Los Angeles, California and will feature 180 companies in the small/micro-cap space. View MariMed's profile here: https://www.ldmicro.com/profile/MRMD.

MariMed Added to Marijuana Index

MariMed has recently been added to MJIC Inc.'s U.S. Marijuana Index (www.marijuanaindex.com) of top performing publicly traded cannabis businesses that meet MJIC minimum trading requirements which include: achieving a weighted average minimum market capitalization of US$30 million, daily trading volume of US$400,000, and share price of US$0.10. Companies with more than US$5 million of revenue over the prior year are exempt from these trading requirements. MariMed is one of only 17 companies in the U.S. that the index follows.

Profiles powered by LD Micro.

News Compliments of ACCESSWIRE.

About MariMed Inc.

MariMed is an industry leader in the development and operation of state-licensed regulatory compliant cannabis cultivation, production, and dispensary facilities in multiple states across the country. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed products for the treatment of specific medical conditions. It currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries. MariMed Inc. is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index (www.marijuanaindex.com). For more info, visit www.MarimedAdvisors.com.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact Mr. David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

For MariMed
Business Development
Jon Levine, CFO, MariMed
+1 844-244-0200

Investor Relations
Tyler Troup, Circadian Group
tyler@circadian-group.com
+1 (866) 950 8300

Media Relations
Julie Shepherd, Accentuate PR
Julie@accentuatepr.com
+1 847-275-3643

SOURCE: MariMed Inc.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.